Phreesia had its Relative Strength (RS) Rating upgraded from 80 to 83 Friday.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's unique RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves.
Phreesia is working on a consolidation with a 30.53 entry. See if it can clear the breakout price in volume at least 40% above average.
The company posted 0% earnings growth in the latest quarterly report. Revenue rose 15%.
The company holds the No. 6 rank among its peers in the Computer Software-Medical industry group. Veeva Systems Cl A, OptimizeRx and Waystar Holding are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
